NCT00835731

Misoprostol Versus Dilapan-S for Cervical Preparation

Cervical Preparation Before Same-day Second Trimester Abortion With Buccal Misoprostol Versus Dilapan-S: A Randomized Placebo Controlled Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 125 (actual)
• Sponsor: Planned Parenthood League of Massachusetts · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to compare the dilatory effect of 400 mcg of buccally administered misoprostol to one Dilapan-S rod placed 3-4 hours before abortion by dilation and evacuation in women who are 12 weeks 0 days to 15 weeks 0 days gestation.

Conditions

• Cervical Ripening

Interventions

Type	Name	Description
DRUG	misoprostol	400mcg misoprostol, buccal administration, 1 time dosing 3-4 hours before abortion by D\&E
DEVICE	Dilapan-S, vitamin B-12	One Dilapan-S rod placed in the cervix 3-4 hours before abortion by D\&E. Control: 1000mcg vitamin B-12, buccal administration 3-4 hours before abortion by D\&E

Timeline

• Start date: 2009-01-01
• Primary completion: 2011-12-01
• Completion: 2011-12-01
• First posted: 2009-02-04
• Last updated: 2017-10-23
• Results posted: 2014-01-07

Locations

1 site across 1 country: United States